Market Cap 150.40B
Revenue (ttm) 28.75B
Net Income (ttm) 480.00M
EPS (ttm) N/A
PE Ratio 14.97
Forward PE 15.02
Profit Margin 1.67%
Debt to Equity Ratio 1.16
Volume 10,417,000
Avg Vol 7,310,530
Day's Range N/A - N/A
Shares Out 1.24B
Stochastic %K 11%
Beta 0.32
Analysts Strong Sell
Price Target $133.04

Company Profile

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis....

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 650 574 3000
Fax: 650 578 9264
Address:
333 Lakeside Drive, Foster City, United States
None_
None_ Dec. 6 at 8:39 PM
$GILD Kite Announces New Data for Pivotal iMMagine-1 Study at ASH 2025, Highlighting Anito-cel’s Opportunity in Relapsed or Refractory Multiple Myeloma https://www.businesswire.com/news/home/20251206049158/en/Kite-Announces-New-Data-for-Pivotal-iMMagine-1-Study-at-ASH-2025-Highlighting-Anito-cels-Opportunity-in-Relapsed-or-Refractory-Multiple-Myeloma
0 · Reply
None_
None_ Dec. 6 at 8:38 PM
$GILD Kite’s Next-Generation Bicistronic CAR T-Cell Therapies Show Encouraging Phase 1 Results in Relapsed/Refractory B-Cell Lymphoma in New Data at ASH 2025 https://finance.yahoo.com/news/kite-next-generation-bicistronic-car-190000916.html
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 6 at 5:44 AM
Enter: $GILD Calls Strike Price: $123 Expiry Date: DEC 26 2025 Buy in Price: $2.75 - $3.90 Sell Price: $6.67 Profit : +71% (Turn every $1 into $1.71) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 1:25 AM
Actionable Trade Alert for $GILD: Market Context: $GILD closed at $122.62, currently trading below its 30-day moving average (MA30) of $123.12, indicating a potential bearish sentiment. The RSI at 43.71 suggests that the stock is nearing oversold conditions, providing a possible reversal opportunity. Directional Bias: With the 60-day high at $128.7 and low at $108.46, the stock has a defined range. The current price is closer to the 60D low, which could support a bullish reversal if momentum shifts. Trade Plan: - Suggested Entry: $122.50 - Stop Loss: $119.50 (2.5% below entry) - Take Profit Targets: 1. $125.00 (2% ROI) 2. $128.00 (4.05% ROI) 3. $143.00 (16.61% ROI) This plan offers a solid potential for a 17% ROI or more on the third target, aligning with the resistance levels and market conditions. Monitor RSI and price action for confirmation. https://privateprofiteers.com
0 · Reply
Fingerlickengood
Fingerlickengood Dec. 5 at 11:36 PM
$MRK $GILD IMHO, even just a small slice in regards to licensing fees for $CDXS would have a HUGE impact on the company going forward. "Pifeltro-islatravir will reach blockbuster status by 2030, with the combination estimated to pull in $1.7BN by 2033, as per a patient-based forecast from analysts at GlobalData. However, islatravir could have another shot at glory on the HIV market, as two Phase III trials are currently assessing islatravir plus Gilead’s HIV drug, Sunlenca (lenacapavir). The combination was recently found to maintain viral suppression for two years when administered orally once-weekly in a Phase II trial." https://www.clinicaltrialsarena.com/news/msd-merck-hiv-doravirine-islatravir-phase-iii/?cf-view
1 · Reply
DomLuminous
DomLuminous Dec. 5 at 5:54 PM
$GILD this should not be going down
0 · Reply
Reanimated666
Reanimated666 Dec. 5 at 5:08 PM
$GILD Why is this ultimate breakout like a root canal without Novocain
0 · Reply
Quantumup
Quantumup Dec. 5 at 4:01 PM
Leerink y'day⬆️ $IMTX's PT to $17 from $16 and reiterated at an Outperform rating. $IMCR $IDYA $GILD AZN AMGN $IOVA Here's what Leerink said in its research note: https://x.com/Quantumup1/status/1996972164738691486?s=20
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 4 at 10:08 PM
Enter: $GILD Calls Strike Price: $125 Expiry Date: DEC 26 2025 Buy in Price: $2.70 - $3.65 Sell Price: $4.67 Profit : +73% (Turn every $1 into $1.73) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
skcots_13
skcots_13 Dec. 4 at 6:57 PM
$GILD aside from @ATOMICALERTS paid alerts, alway bouncing for bull to bear. i'm bullish for ulterior motives. I like to see you, but then again That doesn't mean you mean that much to me So if I call you, don't make a fuss Don't tell your friends about the two of us
0 · Reply
Latest News on GILD
Gilead Sciences: About To Break Out

Nov 25, 2025, 6:17 AM EST - 11 days ago

Gilead Sciences: About To Break Out


2 Supercharged Dividend Stocks to Buy Now

Nov 13, 2025, 10:07 AM EST - 23 days ago

2 Supercharged Dividend Stocks to Buy Now

AMGN


Can Gilead Stock Outrun Regeneron In The Next Rally?

Nov 13, 2025, 9:00 AM EST - 23 days ago

Can Gilead Stock Outrun Regeneron In The Next Rally?


Gilead Provides Update on Phase 3 ASCENT-07 Study

Nov 7, 2025, 8:30 AM EST - 4 weeks ago

Gilead Provides Update on Phase 3 ASCENT-07 Study


Gilead Sciences to Present at Upcoming Investor Conferences

Nov 4, 2025, 4:05 PM EST - 4 weeks ago

Gilead Sciences to Present at Upcoming Investor Conferences


Gilead Sciences, Inc. (GILD) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 8:56 PM EDT - 5 weeks ago

Gilead Sciences, Inc. (GILD) Q3 2025 Earnings Call Transcript


Gilead Sciences Announces Third Quarter 2025 Financial Results

Oct 30, 2025, 4:02 PM EDT - 5 weeks ago

Gilead Sciences Announces Third Quarter 2025 Financial Results


What To Expect From Gilead In Q3 2025

Oct 24, 2025, 10:56 AM EDT - 6 weeks ago

What To Expect From Gilead In Q3 2025


Final Trade: F, HAL, MA, GILD

Oct 21, 2025, 6:21 PM EDT - 6 weeks ago

Final Trade: F, HAL, MA, GILD

F HAL MA


Gilead's Trodelvy cuts breast cancer risk by 38% in trial

Oct 19, 2025, 2:33 AM EDT - 6 weeks ago

Gilead's Trodelvy cuts breast cancer risk by 38% in trial


Final Trades: Gilead, Rocket Lab, Palo Alto and Coinbase

Oct 10, 2025, 1:44 PM EDT - 2 months ago

Final Trades: Gilead, Rocket Lab, Palo Alto and Coinbase

COIN PANW RKLB


Dividend Shields: Top 5 Income Stocks

Sep 30, 2025, 12:55 PM EDT - 2 months ago

Dividend Shields: Top 5 Income Stocks

ALEX LTC OMF THG


Hanmi's Oral Delivery Platform Compound Licensed to Gilead

Sep 29, 2025, 5:45 AM EDT - 2 months ago

Hanmi's Oral Delivery Platform Compound Licensed to Gilead


Gilead Sciences: Yeztugo And Trodelvy Make This A Buy Once More

Sep 23, 2025, 6:45 PM EDT - 2 months ago

Gilead Sciences: Yeztugo And Trodelvy Make This A Buy Once More


None_
None_ Dec. 6 at 8:39 PM
$GILD Kite Announces New Data for Pivotal iMMagine-1 Study at ASH 2025, Highlighting Anito-cel’s Opportunity in Relapsed or Refractory Multiple Myeloma https://www.businesswire.com/news/home/20251206049158/en/Kite-Announces-New-Data-for-Pivotal-iMMagine-1-Study-at-ASH-2025-Highlighting-Anito-cels-Opportunity-in-Relapsed-or-Refractory-Multiple-Myeloma
0 · Reply
None_
None_ Dec. 6 at 8:38 PM
$GILD Kite’s Next-Generation Bicistronic CAR T-Cell Therapies Show Encouraging Phase 1 Results in Relapsed/Refractory B-Cell Lymphoma in New Data at ASH 2025 https://finance.yahoo.com/news/kite-next-generation-bicistronic-car-190000916.html
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 6 at 5:44 AM
Enter: $GILD Calls Strike Price: $123 Expiry Date: DEC 26 2025 Buy in Price: $2.75 - $3.90 Sell Price: $6.67 Profit : +71% (Turn every $1 into $1.71) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 1:25 AM
Actionable Trade Alert for $GILD: Market Context: $GILD closed at $122.62, currently trading below its 30-day moving average (MA30) of $123.12, indicating a potential bearish sentiment. The RSI at 43.71 suggests that the stock is nearing oversold conditions, providing a possible reversal opportunity. Directional Bias: With the 60-day high at $128.7 and low at $108.46, the stock has a defined range. The current price is closer to the 60D low, which could support a bullish reversal if momentum shifts. Trade Plan: - Suggested Entry: $122.50 - Stop Loss: $119.50 (2.5% below entry) - Take Profit Targets: 1. $125.00 (2% ROI) 2. $128.00 (4.05% ROI) 3. $143.00 (16.61% ROI) This plan offers a solid potential for a 17% ROI or more on the third target, aligning with the resistance levels and market conditions. Monitor RSI and price action for confirmation. https://privateprofiteers.com
0 · Reply
Fingerlickengood
Fingerlickengood Dec. 5 at 11:36 PM
$MRK $GILD IMHO, even just a small slice in regards to licensing fees for $CDXS would have a HUGE impact on the company going forward. "Pifeltro-islatravir will reach blockbuster status by 2030, with the combination estimated to pull in $1.7BN by 2033, as per a patient-based forecast from analysts at GlobalData. However, islatravir could have another shot at glory on the HIV market, as two Phase III trials are currently assessing islatravir plus Gilead’s HIV drug, Sunlenca (lenacapavir). The combination was recently found to maintain viral suppression for two years when administered orally once-weekly in a Phase II trial." https://www.clinicaltrialsarena.com/news/msd-merck-hiv-doravirine-islatravir-phase-iii/?cf-view
1 · Reply
DomLuminous
DomLuminous Dec. 5 at 5:54 PM
$GILD this should not be going down
0 · Reply
Reanimated666
Reanimated666 Dec. 5 at 5:08 PM
$GILD Why is this ultimate breakout like a root canal without Novocain
0 · Reply
Quantumup
Quantumup Dec. 5 at 4:01 PM
Leerink y'day⬆️ $IMTX's PT to $17 from $16 and reiterated at an Outperform rating. $IMCR $IDYA $GILD AZN AMGN $IOVA Here's what Leerink said in its research note: https://x.com/Quantumup1/status/1996972164738691486?s=20
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 4 at 10:08 PM
Enter: $GILD Calls Strike Price: $125 Expiry Date: DEC 26 2025 Buy in Price: $2.70 - $3.65 Sell Price: $4.67 Profit : +73% (Turn every $1 into $1.73) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
skcots_13
skcots_13 Dec. 4 at 6:57 PM
$GILD aside from @ATOMICALERTS paid alerts, alway bouncing for bull to bear. i'm bullish for ulterior motives. I like to see you, but then again That doesn't mean you mean that much to me So if I call you, don't make a fuss Don't tell your friends about the two of us
0 · Reply
GettnFibbywIT
GettnFibbywIT Dec. 4 at 5:12 PM
$GILD $XLV GILD - Still slugging it out around that $123-$124 ish general area, an important area of market memory:
0 · Reply
HedgeAlerts
HedgeAlerts Dec. 4 at 6:58 AM
Hedge Alert Live - Protect Your Portfolio Contract: $GILD $125.00 Put · DEC 12, 2025 Exp Entry Price: $1.88 - $2.25 Exit Price Target: $3.76 Profit Margin: +100% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Jblack500
Jblack500 Dec. 3 at 8:53 PM
$BBIO $GILD $ABBV $ABVX $PFE healthcare sector heating up for 2026. Will see a lot of m&a in 2026...oncology will be a target which makes EXEL a possibility....ABVX has a blockbuster on their hands and I could absolutely see them acquired for 12 to 14 billion
0 · Reply
GettnFibbywIT
GettnFibbywIT Dec. 3 at 5:31 PM
$GILD $XLV Trying to dig in.....Buyers/sellers battling it out around this level...
0 · Reply
skcots_13
skcots_13 Dec. 3 at 4:03 PM
$GILD wHAT'S THE ytd? nEVEr mINd.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 3 at 3:07 PM
Enter: $GILD Calls Strike Price: $125 Expiry Date: DEC 26 2025 Buy in Price: $2.57 - $2.70 Sell Price: $3.91 Profit : +52% (Turn every $1 into $1.52) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 2 at 5:43 PM
$GILD Share Price: $124.45 Contract Selected: Dec 26, 2025 $125 Calls Buy Zone: $2.12 – $2.62 Target Zone: $3.88 – $4.74 Potential Upside: 72% ROI Time to Expiration: 23 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
HedgeAlerts
HedgeAlerts Dec. 1 at 9:50 PM
Hedge Alert Live - Protect Your Portfolio Contract: $GILD $124.00 Put · DEC 12, 2025 Exp Entry Price: $1.96 - $2.20 Exit Price Target: $4.04 Profit Margin: +106% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
GettnFibbywIT
GettnFibbywIT Dec. 1 at 5:26 PM
$GILD $XLV Little pull back on a price + momentum divergence, with a couple areas/levels of interest for the bulls to hold - should price/momentum continue to wane.....
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 29 at 3:15 PM
Enter: $GILD Calls Strike Price: $126 Expiry Date: DEC 19 2025 Buy in Price: $3.96 - $4.05 Sell Price: $6.10 Profit : +54% (Turn every $1 into $1.54) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
BiotechBonesaw
BiotechBonesaw Nov. 29 at 2:44 PM
$ALT will $GILD or $SNY be the buyer for pemvi? 🧐
0 · Reply
BillionerOfKing
BillionerOfKing Nov. 28 at 9:00 PM
$GILD Current Stock Price: $125.87 Contracts to trade: $125 GILD Nov 28 2025 Call Entry: $0.54 Exit: $0.88 ROI: 64% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply